Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wolz

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Neurology|June 11, 2024
Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease HeterogeneitySophie E Mastenbroek, Arianna Sala, David Vállez García, et al.
Neurobiology of Aging|April 2, 2013
Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairmentLies Clerx, Ineke A van Rossum, Leah Burns, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 14, 2020
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history studyIsadora Lopes Alves, Lyduine E Collij, Daniele Altomare, et al.
Annals of Clinical and Translational Neurology|May 17, 2024
Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter MicrostructureMario Tranfa, Luigi Lorenzini, Lyduine E Collij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2014
Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's diseaseDerek L G Hill, Adam J Schwarz, Maria Isaac, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2024
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History StudyAriane Bollack, Lyduine E Collij, David Vállez García, et al.
Neuroimage. Clinical|November 21, 2025
Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History studyLeonard Pieperhoff, Luigi Lorenzini, Sophie Mastenbroek, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 3, 2021
Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohortSilvia Ingala, Casper De Boer, Larissa A Masselink, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2021
Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3Jennifer Faber, Tamara Schaprian, Koyak Berkan, et al.
Neurology|September 17, 2024
Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without DementiaLuigi Lorenzini, Alessio Maranzano, Silvia Ingala, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Neurology|June 11, 2024
Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease HeterogeneitySophie E Mastenbroek, Arianna Sala, David Vállez García, et al.
Neurobiology of Aging|April 2, 2013
Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairmentLies Clerx, Ineke A van Rossum, Leah Burns, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 14, 2020
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history studyIsadora Lopes Alves, Lyduine E Collij, Daniele Altomare, et al.
Annals of Clinical and Translational Neurology|May 17, 2024
Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter MicrostructureMario Tranfa, Luigi Lorenzini, Lyduine E Collij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2014
Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's diseaseDerek L G Hill, Adam J Schwarz, Maria Isaac, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2024
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History StudyAriane Bollack, Lyduine E Collij, David Vállez García, et al.
Neuroimage. Clinical|November 21, 2025
Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History studyLeonard Pieperhoff, Luigi Lorenzini, Sophie Mastenbroek, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 3, 2021
Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohortSilvia Ingala, Casper De Boer, Larissa A Masselink, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2021
Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3Jennifer Faber, Tamara Schaprian, Koyak Berkan, et al.
Neurology|September 17, 2024
Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without DementiaLuigi Lorenzini, Alessio Maranzano, Silvia Ingala, et al.
Pageof 6